產(chǎn)品展示
HRP標記小鼠抗猴IgG二抗應(yīng)用(附文獻)
點擊次數(shù):0發(fā)布時間:2022/2/8 17:30:43
更新日期:2022/2/8 17:30:43
所 在 地:中國大陸
產(chǎn)品型號:
優(yōu)質(zhì)供應(yīng)
詳細內(nèi)容
艾美捷/HRP標記小鼠抗猴IgG二抗概述:
克。篠B108a
同型:小鼠(BALB/c)IgG1k
免疫原:Rhesus IgG
特異性:Rhesus and cynomolgus IgG
對人和兔免疫球蛋白、山羊IgG和小鼠、大鼠、倉鼠、豚鼠的低反應(yīng)性,綿羊、驢、牛、馬、豬、貓和雞血清。
艾美捷/HRP標記小鼠抗猴IgG二抗應(yīng)用:
ELISA–質(zhì)量檢測1-8
FLISA–經(jīng)過質(zhì)量測試
FC——文獻9報道
WB——文獻10中有報道
HRP標記小鼠抗猴IgG二抗其他應(yīng)用:由于應(yīng)用不同,需要確定所使用產(chǎn)品的/佳工作稀釋度匹配需求。
HRP標記小鼠抗猴IgG二抗文獻參考:
1. Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI, et al. Programming the magnitude and persistence of antibody responseswith innate immunity. Nature. 2011;470:543-7. (ELISA)
2. Wang J, Tricoche N, Du L, Hunter M, Zhan B, Goud G, et al. The adjuvanticity of an O.volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates. PLoS One. 2012;7(5):e37019. (ELISA)
3. Ferraro B, Talbott KT, Balakrishnan A, Cisper N, Morrow MP, Hutnick NA, et al. Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA. Infect Immun. 2013;81:3709-20. (ELISA)
4. Padte NN, Boente-Carrera M, Andrews CD, McManus J, Grasperge BF, Gettie A, et al. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. PLoS One. 2013;8(10):e78407. (ELISA)
5. Sholukh AM, Watkins JD, Vyas HK, Gupta S, Lakhashe SK, Thorat S, et al. Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge. Vaccine. 2015;33:2086-95. (ELISA)
6. Bolton DL, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human immunodeficiency virus type 1 monoclonal antibodies suppress acute simian-human immunodeficiency virus viremia and limit seeding of cell-associated viral reservoirs. J Virol. 2015;90:1321-32. (ELISA)
7. Yang Z, Wang H, Salcedo TW, Suchard SJ, Xie JH, Schneeweis LA, et al. Integrated pharmacokinetic/pharmacodynamic analysis for determining the minimal anticipated biological effect level of a novel anti-CD28 receptor antagonist BMS-931699. J Pharmacol Exp Ther. 2015;355:506-15. (ELISA)
8. Kutzler MA, Wise MC, Hutnick NA, Moldoveanu Z, Hunter M, Reuter MA, et al. Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge. Mucosal Immunol. 2016;9:13-23. (ELISA)
9. Guo J, Zuo T, Cheng L, Wu X, Tang J, Sun C, et al. Simian immunodeficiency virus infection evades vaccine-elicited antibody responses to V2 region. J Acquir Immune Defic Syndr. 2015;68:502-10. (FC)
10. Parks CL, Koff WC, inventors; International AIDS Vaccine Initiative, assignee. Transgenic Vero-CD4-CCR5 cell line. United States patent applicaton publication US 2017/0266272 A1. 2017 Sep21. (WB)
艾美捷科技是SouthernBiotech的中國代理商,為科研工作者提供優(yōu)質(zhì)的HRP標記小鼠抗猴IgG二抗。
來源:https://www.amyjet.com/products/4700-05.shtml